CCDC13-AS1: A Drug Target / Disease Biomarker (G100874114)

Target Name: CCDC13-AS1

NCBI ID: G100874114

CCDC13-AS1

Other Name(s): CCDC13 antisense RNA 1

CCDC13-AS1: A Drug Target / Disease Biomarker

CCDC13-AS1 is a protein that is expressed in various tissues throughout the body. It is a member of the carbohydrate-rich gene family (CRG), which includes proteins that are involved in a variety of cellular processes, including cell adhesion, migration, and signaling.

One of the unique features of CCDC13-AS1 is its structure. It is a transmembrane protein that is composed of a single polypeptide chain that is expressed in the cytoplasm of the cell. It has a unique topology, with a long cytoplasmic tail that is involved in cell-cell adhesion and a short transmembrane region that is involved in intracellular signaling.

CDC13-AS1 has been shown to play a role in a variety of cellular processes, including cell adhesion, migration, and signaling. For example, it has been shown to be involved in the regulation of cell-cell adhesion in various tissues, including the brain and the placenta. It has also been shown to play a role in the regulation of cell migration, both in the brain and in other tissues.

In addition to its role in cellular processes, CCDC13-AS1 has also been shown to be involved in intracellular signaling. It has been shown to interact with a variety of intracellular signaling proteins, including TGF-β, Wnt, andNotch. These interactions are involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

CDC13-AS1 has also been shown to be involved in a variety of diseases, including cancer. For example, it has been shown to be involved in the regulation of cancer cell invasion and metastasis. It has also been shown to be involved in the regulation of cancer cell angiogenesis, which is the process by which cancer cells develop blood vessels to supply them with oxygen and nutrients.

In conclusion, CCDC13-AS1 is a protein that is expressed in various tissues throughout the body and is involved in a variety of cellular processes, including cell adhesion, migration, and signaling. Its unique structure and function make it an attractive target for research and development as a drug or biomarker. Further studies are needed to fully understand the role of CCDC13-AS1 in various cellular processes and its potential as a therapeutic target.

Protein Name: CCDC13 Antisense RNA 1

The "CCDC13-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC13-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets